Related Experiment Video

Updated: Aug 16, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling

Jason H Clarke1, John Y Cha, Mark D Walsh

  • 1Department of Surgery, University of Colorado Health Sciences Center, Denver, CO, USA.

Journal of the American College of Surgeons
|August 30, 2005
PubMed
Abstract

Insights

Melanoma impairs macrophage anti-tumor activity by suppressing Toll-like receptor 4 (TLR-4) signaling. This leads to reduced tumor necrosis factor-alpha (TNF-alpha) production, hindering immune defense against cancer.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Signaling

Background:

  • Activated macrophages are crucial for anti-tumor immunity through cytokine secretion, antigen presentation, and direct cytotoxicity.
  • Macrophages from tumor-bearing hosts exhibit impaired cytotoxic function and reduced production of key immune mediators like TNF-alpha.
  • Melanoma cells can inhibit macrophage activation in vitro, suggesting a direct suppressive mechanism.

Purpose of the Study:

  • To investigate the hypothesis that melanoma inhibits macrophage activation by suppressing Toll-like receptor 4 (TLR-4) signaling.
  • To elucidate the role of TLR-4 signaling in mediating the suppressive effects of melanoma on macrophage function.

Main Methods:

  • Melanoma conditioned media (MCM) from B16 melanoma cells was used to treat peritoneal macrophages from TLR-4 competent and incompetent mice.
  • Macrophages were stimulated with lipopolysaccharide (LPS) after MCM exposure.
  • Measurements included TNF-alpha secretion, TNF-alpha mRNA levels, nuclear factor-kappaB (NF-kappaB) activation, and TLR-4 surface expression.

Main Results:

  • MCM significantly reduced TNF-alpha secretion in response to LPS in macrophages from TLR-4 competent mice (691 pg/mL vs. 2,066 pg/mL).
  • MCM had no effect on TNF-alpha production in macrophages from TLR-4 incompetent mice.
  • MCM treatment decreased TNF-alpha mRNA and NF-kappaB activation in competent macrophages but did not alter TLR-4 surface expression.

Conclusions:

  • Melanoma inhibits macrophage activation by suppressing TLR-4 signaling pathways downstream of the receptor.
  • This suppression contributes to the impaired anti-tumor immune response observed in melanoma-bearing hosts.
  • Targeting TLR-4 signaling may offer a therapeutic strategy to restore macrophage function in cancer.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...